ATYR: aTyr Pharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 132.64
Enterprise Value ($M) 125.65
Book Value ($M) 81.42
Book Value / Share 1.07
Price / Book 1.63
NCAV ($M) 65.78
NCAV / Share 0.87
Price / NCAV 2.02

Profitability (mra)
Return on Invested Capital (ROIC) -0.61
Return on Assets (ROA) -0.44
Return on Equity (ROE) -0.55

Liquidity (mrq)
Quick Ratio 7.63
Current Ratio 7.63

Balance Sheet (mrq) ($M)
Current Assets 90.30
Assets 105.94
Liabilities 24.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.35
Operating Income -54.92
Net Income -50.39
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.22
Cash from Investing -20.13
Cash from Financing 66.23

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Lytton Laurence W 1.00 -86.82
02-13 13G/A Stonepine Capital Management, LLC 0.80 -89.83
02-09 13G/A Fmr Llc 15.00 101.87
01-18 13G/A Federated Hermes, Inc. 17.37 94.39
01-02 13G Logos Global Management LP 9.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-06 113,443 754,883 15.03
2024-09-05 127,577 494,135 25.82
2024-09-04 29,568 135,860 21.76
2024-09-03 41,579 316,442 13.14

(click for more detail)

Similar Companies
ATNF – 180 Life Sciences Corp. ATOS – Atossa Therapeutics, Inc.
ATXI – Avenue Therapeutics, Inc. AVTX – Avalo Therapeutics, Inc.
AWH – Aspira Women's Health Inc.


Financial data and stock pages provided by
Fintel.io